2Seventy Bio, Inc. (NASDAQ:TSVT) Q4 2023 Earnings Conference Call March 5, 2024 8:00 AM ET Company Participants Elizabeth Hickin - Head, IR Chip Baird - Incoming CEO Vicki Eatwell - Incoming CFO Anna Truppel-Hartmann - SVP, Clinical Development Conference Call Participants Daina Graybosch - Leerink Partners Tommie Reerink - Goldman Sachs & Co. Kelsey Goodwin - Guggenheim Securities Samantha Semenkow - Citigroup Operator Good day, and thank you for standing by. Welcome to the 2seventy bio fourth-quarter 2023 ...